As privileged witnesses of the initiation and widespread use of reperfusion therapy the authors review the history of fibrinolytic therapy and of tissue-plasminogen activator (t-PA) more particularly and the current indications for its use in the era of mechanical reperfusion.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1538-7836.2008.03195.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!